Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
Gadobutrol (Gadovist/Gadavist)
DRUG
2 trials
Sponsors
Bayer
, Insel Gruppe AG, University Hospital Bern
Conditions
Central Nervous System Pathology
Suspect Renal and Adrenal Imaging Findings
Phase 2
Study to Find the Appropriate Dose of a New Gadolinium-based Contrast Agent (GBCA) for Adults Undergoing Magnetic Resonance Imaging (MRI) for Known or Highly Suspected Brain and/or Spinal Cord Conditions
Completed
NCT04307186
Bayer
Central Nervous System Pathology
Start: 2020-11-18
End: 2022-09-06
Updated: 2023-11-15
Phase 4
Randomized Comparison of Contrast Agents Gadopiclenol and Gadobutrol in the Workup of Incidental Renal and Adrenal Findings
Recruiting
NCT07040865
Insel Gruppe AG, University Hospital Bern
Suspect Renal and Adrenal Imaging Findings
Start: 2025-08-18
End: 2027-07-31
Target: 104
Updated: 2025-11-19